Line Borgwardt

537 total citations · 1 hit paper
22 papers, 265 citations indexed

About

Line Borgwardt is a scholar working on Physiology, Genetics and Organic Chemistry. According to data from OpenAlex, Line Borgwardt has authored 22 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 5 papers in Genetics and 4 papers in Organic Chemistry. Recurrent topics in Line Borgwardt's work include Lysosomal Storage Disorders Research (13 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Pineapple and bromelain studies (3 papers). Line Borgwardt is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Pineapple and bromelain studies (3 papers). Line Borgwardt collaborates with scholars based in Denmark, Italy and Germany. Line Borgwardt's co-authors include Allan M. Lund, Christine í Dali, Birgitte Bertelsen, Miyako Kodama, Federica Cattaneo, Finn Cilius Nielsen, Nathalie Guffon, Frederik Otzen Bagger, Diego Ardigò and Yasmina Amraoui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Acta Paediatrica.

In The Last Decade

Line Borgwardt

22 papers receiving 263 citations

Hit Papers

Whole genome sequencing in clinical practice 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Line Borgwardt Denmark 9 126 78 58 50 39 22 265
Amal Aqul United States 7 169 1.3× 75 1.0× 53 0.9× 39 0.8× 52 1.3× 14 286
Elisabeth Jameson United Kingdom 11 185 1.5× 120 1.5× 88 1.5× 18 0.4× 37 0.9× 22 402
Fernanda Bender Brazil 10 216 1.7× 62 0.8× 117 2.0× 21 0.4× 50 1.3× 28 300
Hsuan-Chieh Liao Taiwan 8 247 2.0× 86 1.1× 96 1.7× 11 0.2× 56 1.4× 8 315
Marie Jackson United Kingdom 11 233 1.8× 124 1.6× 92 1.6× 16 0.3× 64 1.6× 21 384
Hilde Monica Frostad Riise Stensland Norway 12 139 1.1× 109 1.4× 43 0.7× 34 0.7× 56 1.4× 18 245
Minke H. de Ru Netherlands 7 334 2.7× 48 0.6× 159 2.7× 19 0.4× 87 2.2× 9 408
Michal Inbar‐Feigenberg Canada 10 111 0.9× 191 2.4× 37 0.6× 12 0.2× 24 0.6× 30 419
Sabrina Eichler Germany 10 251 2.0× 111 1.4× 94 1.6× 10 0.2× 77 2.0× 15 324
Sue Ann Smith United States 5 253 2.0× 70 0.9× 99 1.7× 10 0.2× 67 1.7× 6 313

Countries citing papers authored by Line Borgwardt

Since Specialization
Citations

This map shows the geographic impact of Line Borgwardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Borgwardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Borgwardt more than expected).

Fields of papers citing papers by Line Borgwardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Line Borgwardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Borgwardt. The network helps show where Line Borgwardt may publish in the future.

Co-authorship network of co-authors of Line Borgwardt

This figure shows the co-authorship network connecting the top 25 collaborators of Line Borgwardt. A scholar is included among the top collaborators of Line Borgwardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Line Borgwardt. Line Borgwardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guffon, Nathalie, Line Borgwardt, Anna Tylki‐Szymańska, et al.. (2024). Extended long‐term efficacy and safety of velmanase alfa treatment up to 12 years in patients with alpha‐mannosidosis. Journal of Inherited Metabolic Disease. 48(1). e12799–e12799. 2 indexed citations
2.
Bagger, Frederik Otzen, et al.. (2024). Whole genome sequencing in clinical practice. BMC Medical Genomics. 17(1). 39–39. 56 indexed citations breakdown →
3.
Bliddal, Sofie, Line Borgwardt, Maria Rossing, et al.. (2022). Severe weight loss in a hypothyroid patient as an acute presentation of autoimmune polyglandular syndrome type II. HORMONES. 21(2). 317–322. 3 indexed citations
4.
Nazaryan‐Petersen, Lusine, Miglė Gabrielaitė, Joanne Reekie, et al.. (2022). Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling. Frontiers in Immunology. 13. 906328–906328. 10 indexed citations
5.
Tofteng, Charlotte Landbo, et al.. (2021). Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report. Journal of Medical Case Reports. 15(1). 471–471. 5 indexed citations
7.
Lund, Allan M., Nathalie Guffon, Mercedes Gil‐Campos, et al.. (2021). Effect of velmanase alfa (human recombinant alpha-mannosidase) enzyme-replacement therapy on quality of life and disease burden of patients with alpha-mannosidosis: Results from caregiver feedback. Molecular Genetics and Metabolism. 132(2). S67–S67. 2 indexed citations
8.
Phillips, Dawn, Julia B. Hennermann, Anna Tylki‐Szymańska, et al.. (2020). Use of the Bruininks-Oseretsky test of motor proficiency (BOT-2) to assess efficacy of velmanase alfa as enzyme therapy for alpha-mannosidosis. Molecular Genetics and Metabolism Reports. 23. 100586–100586. 9 indexed citations
9.
Junker, Anders, Karen Vagner Danielsen, E. Dahl, et al.. (2020). Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature. World Journal of Clinical Cases. 8(9). 1642–1650. 7 indexed citations
10.
Hennermann, Julia B., Nathalie Guffon, Federica Cattaneo, et al.. (2020). The SPARKLE registry: protocol for an international prospective cohort study in patients with alpha-mannosidosis. Orphanet Journal of Rare Diseases. 15(1). 271–271. 6 indexed citations
11.
12.
Hennermann, Julia B., Nathalie Guffon, Federica Cattaneo, et al.. (2019). The SPARKLE study: Shedding light on alpha mannosidosis. Molecular Genetics and Metabolism. 126(2). S71–S72. 2 indexed citations
13.
14.
Harmatz, Paul, Federica Cattaneo, Diego Ardigò, et al.. (2018). Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis. Molecular Genetics and Metabolism. 124(2). 152–160. 30 indexed citations
15.
Borgwardt, Line, Nathalie Guffon, Yasmina Amraoui, et al.. (2018). Health Related Quality of Life, Disability, and Pain in Alpha Mannosidosis. SHILAP Revista de lepidopterología. 6. 4078291845–4078291845. 5 indexed citations
16.
Borgwardt, Line, Hilde Monica Frostad Riise Stensland, Flemming Wibrand, et al.. (2015). Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation. Orphanet Journal of Rare Diseases. 10(1). 70–70. 32 indexed citations
17.
Borgwardt, Line, Allan M. Lund, & Christine í Dali. (2014). Alpha-mannosidosis - a review of genetic, clinical findings and options of treatment.. PubMed. 12 Suppl 1. 185–91. 26 indexed citations
18.
Borgwardt, Line, et al.. (2012). Enzyme Replacement Therapy for Patients with Alpha-Mannosidosis. Molecular Genetics and Metabolism. 105(2). S21–S21. 2 indexed citations
19.
Gutte, Henrik, Michael Möller, Jørgen Thorup, et al.. (2010). Estimating GFR in children with 99mTc‐DTPA renography: a comparison with single‐sample 51Cr‐EDTA clearance. Clinical Physiology and Functional Imaging. 30(3). 169–174. 16 indexed citations
20.
Borgwardt, Line, et al.. (2008). Elective caesarean section increases the risk of respiratory morbidity of the newborn. Acta Paediatrica. 98(1). 187–189. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026